Orchestra BioMed Holdings, Inc. (OBIO) Gross margin 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) gross margin by fiscal year — reported gross profit divided by reported revenue.
99.4%FY2025 · since FY2022: 94.0% → 99.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 99.4% | +7.2 pp |
| FY2024 | 92.3% | -1.0 pp |
| FY2023 | 93.3% | -0.8 pp |
| FY2022 | 94.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net incomeOBIO Net marginOBIO Gross profitOBIO Operating incomeOBIO Operating marginOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →